Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1tirzepatidepneumatosis intestinaliscase reportgi safety

Pathologists report histologic case of tirzepatide-linked pneumatosis intestinalis

A 55-year-old man on tirzepatide for about a year improved after stopping the drug, with biopsies showing air-filled mucosal and submucosal spaces.

MH
By Maren Holt · Senior Reporter, GLP-1

The wire

  1. 01In the American Journal of Clinical Pathology, authors describe what they call the first documented histologic diagnosis of possible tirzepatide-associated pneumatosis intestinalis, found on colon biopsy during colonoscopy for abdominal pain and constipation.
  2. 02Clinicians managing incretin patients with persistent GI complaints now have described histologic features, including foreign body-type giant cell reactions and eosinophil- and neutrophil-rich infiltrates, to aid recognition.
  3. 03This is a single case report in a patient with obesity, type 2 diabetes, hypertension and sleep apnea who had lost 49 pounds; causation is not established and the authors call for further reporting.

From the source

Tirzepatide-induced pneumatosis intestinalis: a rare but clinically significant gastrointestinal adverse effect

American journal of clinical pathology · 2026 Oct 10 · Kassardjian A, Shafizadeh N et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →